EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
20 hedge funds and large institutions have $86.5M invested in ESSA Pharma in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.94% less ownership
Funds ownership: 68.44% → 67.51% (-0.94%)
Holders
20
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.24M | |
| 2 | +$1.08M | |
| 3 | +$780K | |
| 4 |
Renaissance Technologies
New York
|
+$234K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$20.1K |
Top Sellers
| 1 | -$2.7M | |
| 2 | -$1.19M | |
| 3 | -$682K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.26K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |